Skip to content

Evaluation on post treatment pain in patients undergoing Root Canal Treatment with 3 agents Lignocaine,sodium Diclofenac, Ketorolac tromethamine.

A Comparative Evaluation Of Anesthetic Efficiency Of Nerve Block Along With Adjuvant Intraligamentary Injection Of lignocaine, Diclofenac sodium And Ketorolac Tromethamine On Reduction Of Intra Appointment Endodontic Pain In Normal And Hypertensive Patients With Irreversible Pulpitis - A Randomized Clinical Study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027635
Enrollment
198
Registered
2020-09-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K040- Pulpitis

Interventions

Intervention1: Non Steroidal Anti-inflammatory Drug: Cartridge of diclofenac sodium 30mg/ml. to inject 0.06ml into four sites so 0.24 ml per tooth Intervention2: Non Steroidal Anti-inflammatory Drug:

Sponsors

Dr Meghna Kothari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The patients between 18 to 60 years of age with mandibular teeth where mandibular nerve block is required to anesthetize the tooth. 2. Patients diagnosed with irreversible pulpitis with hot tooth. 3. Patients having history of stage 1 and 2 hypertension and undergoing regular treatment. 4. Patients having no systemic diseases other hypertension would be included. 5. Patient should have actively experiencing moderate to severe pain on VAS scale of 5 or more. 6. Teeth with no well defined periapical radiolucency seen on radiographic examination. 7. Patients with history of previous initiation root canal therapy. 8. A written informed consent will be taken from all the patients and only those patients ready to sign the consent letter

Exclusion criteria

Exclusion criteria: 1. Patients with known hypersensitivity to diclofenac sodium, ketorolac tromethamine and lignocaine. 2. Patients who are pregnant or lactating 3. Patients who are contraindicated for NSAIDs 4. Patients who have undergone cardiac surgery in last 6 months 5. Patients with fractured or visibly cracked tooth, developmental anomalies, pathology or open apex related to study teeth. 6. Patients who had taken NSAIDS within 24 hrs before administration of study drug. (antibiotic as such no criteria required) â??

Design outcomes

Primary

MeasureTime frame
Intraligamentary Injections are known to reduce the pain after giving nerve block in cases of irreversible pulpitis. The generally used agent is lignocaine but other drugs like diclofenac sodium and ketorolac tromethamine are also proved to reduce the intra-appointment painTimepoint: At Baseline and Second after getting drop inside the pulp chamber

Secondary

MeasureTime frame
To evaluate post operative pain following Intraligamentry Injection using lignocaine, diclofenac sodium, ketorolac tromethamineTimepoint: At Baseline and Second after gaining access to pulp chamber

Countries

India

Contacts

Public ContactDr Meghna A Kothari

dept of conservative dentistry and endodontics K M Shah Dental College And Hospital

nshah7873@gmail.com9998994299

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026